The aim of this study was to confirm the reported elevated levels of sVAP-1 in patients with CRC compared with controls and determine if differences observed in sVAP-1 levels are reflected by changes in tissue VAP-1 expression. The gene discussed is AOC3; the disease is colorectal carcinoma.